Sino-American oncology-focused biotech BeOne Medicines has announced positive top-line results from the second interim ...

Swiss pharma giant Novartis said its Phase III REMODEL-1 and REMODEL-2 trials of remibrutinib met their primary endpoint, ...

US biotech major Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk adults ...

Immunic, a late-stage biotech developing oral therapies for neurological diseases, has appointed Chitrang Davé as chief data ...

RedHill Biopharma today announced the transformational acquisition of exclusive global and US commercialization rights to ...

The White House has announced that nine additional pharmaceutical manufacturers have signed most-favored-nation (MFN) pricing ...

Swiss pharma major Novartis (NOVN: VX) has temporarily halted eight early- and mid-stage trials of its experimental cell ...

USA-based infectious disease biotech firm EIT Pharma has closed an oversubscribed $35 million series A round, led by Propel ...

German pharma major Bayer’s wholly-owned and independently operated subsidiary AskBio has announced the presentation of ...

US biotech major Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk adults ...

RedHill Biopharma on Monday announced the divestment of its 70% stake in the Talicia business to a subsidiary of Apotex ...

US pharma major Eli Lilly is continuing its streak of M&A activity, inking an agreement to acquire Merida Biosciences, a ...